Parisi Theodora Internist
Assistant Director, 2nd Internal Medicine Department HYGEIA HospitalEducation & Academic Qualifications
- University of Patras Medical School, Medical Degree (1999)
- University of Athens Medical School, Department of Clinical Therapeutics, General Hospital “Alexandra”, Specialization in Internal Medicine (2003-2008)
Doctoral thesis
Master of Science (MSc.) in Immunology, Postgraduate Program in “Basic Medical Sciences” of the University of Patras Medical School (2001-2003)
aUniversity of Athens Medical School, PhD Thesis: “Study on blood glucose and blood pressure variations during the acute phase of ischaemic stroke” (in process)
Fellowship in Societies, Membership in Journal Editorial Committees
Athens Medical Association
Hellenic Society of Internal Medicine
Hellenic Association for the Study of Liver Diseases
Work Experience
General Prefectural Hospital of Aegion, Aegion (2001)
General Hospital “Ag. Andreas”, Patras, Cardiology Department (2000-2001)
General Hospital “Alexandra”, Department of Clinical Therapeutics (2003-2008)
Hygeia Hospital, Department of Internal Medicine, Attending Physician (2009-present)
Private practice (2009-present)
Clinical & Research Interest
Clinical Interest:
Immunology
Preventive Medicine
Infectious Diseases
Evidenced based medicine
Geriarics
Research Interest:
AVERROES study (NCT00496769): “Αpixaban VErsus aspirin [acetyl salicylic acid- ASA] to Reduce the Rate Of Embolic Stroke”
Biochemical markers modulation in various Infectious Diseases
Recent Publications
Clinical and Laboratory findings in patients with Influenza during the period 2012-2013. Cako A, Parissi T, Fanis P, Doukas C, Georgilis K. 14th Annual Panhellenic Congress of the Hellenic Society of Infectious Diseases. Athens, March 2014.
Hydrochlorothiazide causes dilatation of the penile cavernosal arteries [abstract] G. Rammos, K. Syrgiannis, V. Peppes, E. Feida, T. Parisi, N. Kokolakis, N. Zakopoulos. Int Angiology. 2008;27 Suppl 1(3):118.
Synthetic peptides mapping to epitopes of the extracellular domain of the Interleukin-2 receptor beta-chain to inhibit T-cell activation. . Parissi T, Chatzantoni K, Deraos S, Matsoukas I, Mouzaki A. Tranplant Proc. 2004Jul- Aug;36(6):1723-7
Synthetic peptides mapping to epitopes of the extracellular domain of the Interleukin-2 receptor beta-chain to inhibit T-cell activation. Parissi T, Chatzantoni K, Deraos S, Matsoukas I, Mouzaki A. Immunology Lett. 2003 Jun 2;87(1-3):1-351